An interactive report showing what has happened to Lloydspharmacy, formerly one of the biggest NHS community pharmacy chains in the UK. Scroll down to read on.
Lloyds Chemist was founded in 1973 when pharmacist Allen Lloyd purchased his first pharmacy in Polesworth, Warwickshire.
Over the next two decades, the company would grow through acquisitions of independent pharmacies and regional groups, before being purchased in 1997 by Celesio AG, who had bought AAH Pharmaceuticals and the Hills Pharmacy group two years previously.
Celesio were in turn purchased by McKesson Corporation in 2014.
In 2015, Lloydspharmacy agreed to buy Sainsbury's pharmacy business for £125 million, which comprised of 281 pharmacies (277 within Sainsbury's stores and 4 within hospitals). This brought the total number of UK Lloydspharmacy branches to around 1,800.
To satisfy the Competition and Markets Authority (CMA), Lloydspharmacy was forced to sell at least 12 pharmacies so as to not reduce patient choice in these areas:
In a surprise announcement in October 2017, Lloydspharmacy announced the closure of 190 commercially unviable branches. The managing director at the time, Cormac Tobin, stated:
Changes to government policy on reimbursement and retrospective clawbacks over the past two years have gradually made operations at many LloydsPharmacy stores commercially unviable. We will be doing all that we can to support our affected colleagues and minimise disruption for patients.
Mr Tobin resigned a week later.
Over the next 12 months, 190 branches of Lloydspharmacy would either close permanently or be sold.
In 2019, McKesson purchased Echo, a UK-based startup which offered patients free medication delivery and prescription management through a smartphone app.
At that time, Lloydspharmacy already had their own newly-launched online pharmacy with around 4,000 EPS nominated patients, whereas Echo had around 30,000.
After a period of growth, especially during the COVID-19 pandemic, Echo rebranded as LloydsDirect in 2021. At that point, it had grown to around 500,000 EPS nominated patients.
In 2021, McKesson sold its European business to the Phoenix Group, and its UK business to private equity firm Aurelius Group. The completion of the sale of McKesson UK was announced in April 2022.
In January 2023, LloydsPharmacy announced their intention to withdraw operations from all Sainsbury's stores. This was announced to take place over the course of 2023, and would affect 237 LloydsPharmacy branches within Sainsbury's locations.
In February 2023, a set of projects to sell a significant number of LloydsPharmacy branches in England, Scotland and Wales was revealed. Aurelius declined to comment on suggestions that it was planning to sell all branches of LloydsPharmacy, or that it intended to stop providing pharmacy services to the Scottish prison service.
Data availability for pharmacy sales and closures varies by country; see below graph of pharmacy branches over time to see the latest dates for which data is available and used in the above map.
The data within this report, including details of pharmacy sales and pharmacy ownership, is from PharmDirectory and is updated at least once per day.